percentage of us population on glp 1 2025 UPDATE – The GLP-1 revolution will shrink orthopedic surgeries Study: US obesity rates are

There can be side effects and risks: GLP-1 drugs affect multiple systems (pancreas, kidney, GI tract) and are not without cost or health implications

Abstract Recent clinical trials investigating cardiovascular (CV) safety of newer antidiabetic agents have been rapidly and largely changing the landscape of diabetes care and providing highly important clinical information on decision-making regarding the choice of antidiabetic agents

( PMID: 8642087 ) DeYoung MB, MacConell L, Sarin V, Trautmann M, Herbert P (2011) Encapsulation of exenatide in poly-(d, l-lactide-co-glycolide) microspheres produced an investigational long-acting once-weekly formulation for type 2 diabetes

There have been post-marketing reports of acute pancreatitis with liraglutide 3.0 mg

By contrast, Medicaid acuity and utilization challenges appear to have subsided somewhat

Below is a clear breakdown of why monitoring matters and which tests are commonly recommended for people using GLP-1 medications